Seko Logistics and Peli BioThermal partner for pharma operations in Ireland
07 / 04 / 2021
Left to right: Michael Daly, MD; Damian Denton, ops manager; Oisin Lynch, logistics ops; Paddy Byrne, warehouse manager; Brian Stears, ops director; Gareth McCaffrey, key account manager, all at Seko.
Seko Logistics has broadened its pharma capabilities in Ireland by opening a new 30,000 sq ft facility in Dublin and extending its partnership with temperature-controlled container manufacturer Peli BioThermal.
The companies said the partnership will give Seko’s customers in Ireland “quick and easy access” to Peli BioThermal’s temperature-controlled solutions, which offer storage between 2 and 8°C and 15-25°C depending on the container type.
Seko added that the partnership “leverages” its international freight forwarding network, as well as enabling Peli BioThermal to enhance its pharma service in Ireland by utilising Seko’s network and facilities at the Dublin hub.
The deal will also see Seko servicing refurbishing, repairing and conditioning shippers from Peli BioThermal’s Crēdo rental programme to help pharma goods to arrive at their destination “intact and effective, protected from exterior environments”.
A spokesperson for Seko Logistics explained: “Under the newly extended partnership, Seko now provides international movements of Crēdo Cargo units by air, sea and road transportation, offering Import, export and in-house Customs Brokerage services. Seko has also opened a new Crēdo Cube refurbishment operation within the facility with a GDP-certified team of staff.”
Michael Daly, managing director at Seko Logistics in Ireland, commented: “One of our reasons for moving to a bigger facility in Dublin was to show Peli BioThermal that we are a long-term partner ready to support their growth over the next 3-5 years. We want to help them grow more and, in doing so, show Ireland’s pharma industry the benefits we can offer by centralising their requirements with us. By combining Peli BioThermal with Seko’s international freight forwarding network and customs services, we can simplify pharma supply chains and make them more efficient.”
Adam Tetz, director of worldwide marketing at Peli BioThermal, added: “Seko’s new facility has made it easier and more cost efficient to set up these other services and sets a precedent for future network stations. We see massive growth potential in Ireland and the availability of these additional services broadens our scope.”
According to IDA Ireland, an autonomous statutory agency operating under the aegis of the Minister for Business, Enterprise and Innovation, the world’s top 10 bio pharmaceutical companies, and 14 of the world’s top 15 medical technology companies, all have operations in Ireland.
In addition, 75 pharma companies in Ireland contribute to the €39bn generated annually from exports connected to the pharma, bio and chemistry sectors.
